Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR4 | O00206 | 2/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2270780 | 1.00 | TLR4 (0.38) | TLR4CYP2C9ALDH1A1LMNAMAPT | |
| SCHEMBL7746227 | 1.00 | TLR4 (0.38) | TLR4CYP2C9ALDH1A1LMNAMAPT | |
| SCHEMBL2270772 | 1.00 | TLR4 (0.38) | TLR4CYP2C9ALDH1A1LMNAMAPT | |
| SCHEMBL7746236 | 1.00 | TLR4 (0.38) | TLR4CYP2C9ALDH1A1LMNAMAPT | |
| SCHEMBL2270775 | 1.00 | TLR4 (0.38) | TLR4CYP2C9ALDH1A1LMNAMAPT | |
| SCHEMBL7746238 | 1.00 | TLR4 (0.38) | TLR4CYP2C9ALDH1A1LMNAMAPT | |
| SCHEMBL8488915 | 0.94 | CYP2C9 (0.36) | TLR4CYP2C9ALDH1A1LMNAMAPT | |
| SCHEMBL1300087 | 0.94 | CYP2C9 (0.36) | TLR4CYP2C9ALDH1A1LMNAMAPT | |
| SCHEMBL10832530 | 0.91 | CYP2C9 (0.35) | TLR4CYP2C9ALDH1A1LMNAMAPT | |
| SCHEMBL10832533 | 0.91 | CYP2C9 (0.35) | TLR4CYP2C9ALDH1A1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112961042-B | Synthesis method of trans-4- (trans-4' -alkyl cyclohexyl) cyclohexyl formaldehyde | 惠泽化学科技(濮阳)有限公司 | 2024-05-31 | — | — | CN | disclosed |
| CN-113372208-A | Preparation method of trans-4- (trans-4-alkylcyclohexyl) cyclohexanecarboxaldehyde | 山东盛华电子新材料有限公司 | 2021-09-10 | — | — | CN | disclosed |
| CN-112961042-A | Synthesis method of trans-4- (trans-4' -alkylcyclohexyl) cyclohexyl formaldehyde | 惠泽化学科技(濮阳)有限公司 | 2021-06-15 | — | — | CN | disclosed |
| EP-1873134-B1 | CHLOROFLUOROBENZENE LIQUID CRYSTALLINE COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC CORP (JP) | 2013-02-13 | — | — | EP | disclosed |
| US-7758931-B2 | Chlorofluorobenzene liquid crystal compound, liquid crystal composition, and liquid crystal display device | CHISSO CORPORATION (JP) | 2010-07-20 | — | — | US | disclosed |
| US-20090264683-A1 | CHLOROFLUOROBENZENE LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | CHISSO CORPORATION (JP) | 2009-10-22 | — | — | US | disclosed |
| US-7569258-B2 | Chlorofluorobenzene liquid crystal compound, liquid crystal composition, and liquid crystal display device | CHISSO CORPORATION (JP) | 2009-08-04 | — | — | US | disclosed |
| EP-1873134-A1 | CHLOROFLUOROBENZENE LIQUID CRYSTALLINE COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | Chisso Corporation (JP) | 2008-01-02 | — | — | EP | disclosed |
| US-20060198968-A1 | cyclohexenylene compounds which have a phenylene ring both fluoro and chloro substituted; wide temperature range; heat and light stable; small viscosity, large optical anisotropy; suitable negative dielectric anisotropy and excellent compatibility with other liquid crystal compounds; short response times | JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) | 2006-09-07 | — | — | US | disclosed |
| EP-1179522-B1 | Liquid crystalline compound having a difluoropropyleneoxy group as bonding group, liquid crystal composition and liquid crystal display element | CHISSO CORP (JP) | 2005-12-07 | — | — | EP | disclosed |
| EP-0393501-B1 | LIQUID CRYSTAL COMPONENTS WITH A TRANS-3-CYCLOHEXYLALLYLOXY GROUP | F. HOFFMANN-LA ROCHE AG (CH) | 1993-06-23 | — | — | EP | disclosed |
| EP-0325796-B1 | A LIQUID CRYSTAL COMPOUND AND A MIXTURE CONTAINING THE SAME | Chisso Corporation (JP) | 1992-03-11 | — | — | EP | disclosed |
| US-5032312-A | Liquid crystals | HOFFMANN-LA ROCHE INC. (US) | 1991-07-16 | — | — | US | disclosed |
| EP-0425622-A1 | MESOGENIC COMPOUNDS. | MERCK PATENT GMBH (DE) | 1991-05-08 | — | — | EP | disclosed |
| WO-1990013610-A1 | MESOGENIC COMPOUNDS | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1990-11-15 | — | — | WO | disclosed |
| EP-0393501-A1 | Liquid crystal components with a trans-3-cyclohexylallyloxy group | F. HOFFMANN-LA ROCHE AG (CH) | 1990-10-24 | — | — | EP | disclosed |
| EP-0381728-A1 | DIFLUOROMETHYL COMPOUNDS. | MERCK PATENT GMBH (DE) | 1990-08-16 | — | — | EP | disclosed |
| WO-1990001056-A1 | DIFLUOROMETHYL COMPOUNDS | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1990-02-08 | — | — | WO | disclosed |
| US-4877548-A | STABLE TO HEAT, LIGHT, ELECTRICITY AND MOISTURE | CHISSO CORPORATION (JP) | 1989-10-31 | — | — | US | disclosed |
| EP-0325796-A1 | A liquid crystal compound and a mixture containing the same | Chisso Corporation (JP) | 1989-08-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090264683-A1 | CHLOROFLUOROBENZENE LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | CCND3, CCND1, SLFN12 | TLR4 4009/4885CYP2C9 2402/4885ALDH1A1 2030/4885 |
| US-20060198968-A1 | cyclohexenylene compounds which have a phenylene ring both fluoro and chloro substituted; wide temperature range; heat and light stable; small viscosity, large optical anisotropy; suitable negative dielectric anisotropy and excellent compatibility with other liquid crystal compounds; short response times | CCND3, CCND1, TCF12 | TLR4 4241/4885CYP2C9 2535/4885ALDH1A1 2356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.